Please login to the form below

Not currently logged in
Email:
Password:

Global Fund

This page shows the latest Global Fund news and features for those working in and with pharma, biotech and healthcare.

Ex-GSK CEO Witty named head of pharmacy benefit firm Optum

Ex-GSK CEO Witty named head of pharmacy benefit firm Optum

UnitedHealth said that Optum Ventures will now include a new $100m global fund that’s dedicated to emerging technology, data analytics and healthcare services.

Latest news

More from news
Approximately 3 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • The world is our laboratory The world is our laboratory

    This year, through J&J Innovation, we will invest $10m into the UK government-led Global Dementia Discovery Fund, supporting innovative research into the area. ... This is a global, not just European, drive; when I attended this year's Annual Meeting for

  • Pharma deals during January 2013 Pharma deals during January 2013

    cancer. BMS held rights to North America and Japan leaving Lilly sole global rights. ... New biotech investment fund. 200. Afraxis / Genentech. Global exclusive licence.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Former PEPFAR head Mark Dybul to lead the Global Fund Former PEPFAR head Mark Dybul to lead the Global Fund

    Former PEPFAR head Mark Dybul to lead the Global Fund. Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics